Cargando…
Hydroxychloroquine and “off-label” utilization in the treatment of oral conditions
Autor principal: | Brown, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151388/ https://www.ncbi.nlm.nih.gov/pubmed/32331804 http://dx.doi.org/10.1016/j.oooo.2020.03.047 |
Ejemplares similares
-
Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020) -
Hydroxychloroquine: Thrombotic microangiopathy following off label treatment: case report
Publicado: (2021) -
Hydroxychloroquine: Stevens-Johnson syndrome following an off-label treatment: case report
Publicado: (2020) -
Hydroxychloroquine: Premature ventricular contractions following an off label treatment: case report
Publicado: (2021) -
Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)